Evidence Level
L-Tryptophan is an essential amino acid that plays a significant role in sleep regulation and mood enhancement. Research has shown that it may reduce sleep latency, though its effect on total sleep duration remains inconsistent (Silber & Schmitt, 2010). A historical event involving L-tryptophan was the 1989 eosinophilia-myalgia syndrome (EMS) outbreak, which was linked to a contaminated batch from a single manufacturer and not the amino acid itself. Currently, pharmaceutical-grade products are considered safe for use.
Several studies have investigated the effects of L-tryptophan on mood and emotional functioning. A systematic review by Kikuchi et al. (2021) analyzed 11 randomized controlled trials and found that supplementation with doses ranging from 0.14 to 3 grams per day significantly reduced anxiety and improved positive mood in healthy adults. Additionally, a meta-analysis by Ogawa et al. (2014) involving 744 patients and 793 controls revealed that plasma L-tryptophan levels are notably lower in individuals with major depressive disorder, particularly among unmedicated participants.
Beyond its role in mood regulation, L-tryptophan is known to support the kynurenine pathway. A systematic review by Carneiro et al. (2018) examined 25 studies and concluded that L-tryptophan administration increases cerebral serotonin levels in animals, with variations observed based on brain region and timing of administration.
In summary, L-Tryptophan demonstrates potential benefits for sleep, mood regulation, and mental health, supported by evidence from multiple studies. Its safety profile has been re-established following historical concerns, making it a viable option for supplementation under appropriate conditions.